PBEF siRNA (h) from Santa Cruz Biotechnology, Inc.

Product Specs
ItemPBEF siRNA (h)
CompanySanta Cruz Biotechnology, Inc.
Price $293.00Supplier Page View Company Product Page
Catalog Numbersc-45843
Gene Namenicotinamide phosphoribosyltransferase
Quantity10 µM
Specieshuman
NCBI Full Gene Namenicotinamide phosphoribosyltransferase
NCBI Gene Aliases1110035O14Rik, PBEF, PBEF1, VF, VISFATIN
TypesiRNA/dsRNA

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Dual Effects of Korean Red Ginseng on Astrocytes and Neural Stem Cells in Traumatic Brain Injury: The HO-1-Tom20 Axis as a Putative Target for Mitochondrial FunctionCellsMarch 4, 2022Kim M, Moon S, Jeon HS, Kim S, Koh SH, Chang MS, Kim YM, Choi YK.

(2) NAMPT promotes hepatitis B virus replication and liver cancer cell proliferation through the regulation of aerobic glycolysisOncology lettersMay 1, 2021Guo HJ, Li HY, Chen ZH, Zhou WJ, Li JJ, Zhang JY, Wang J, Luo XY, Zeng T, Shi Z, et al.Inc.). HepG2.2.15 and HepAD38 cells were transfected with 100 nmol/l of specific NAMPT siRNAs (cat. no. sc-45843; Santa Cruz Biotechnology Inc.) or negative control siRNA (cat. no. sc-37007; Santa Cruz Biotechnology Inc

(3) A Negative Feedback Loop Between NAMPT and TGF-β Signaling Pathway in Colorectal Cancer CellsOncoTargets and therapyJanuary 1, 2021Lv X, Zhang J, Zhang J, Guan W, Ren W, Liu Y, Xu G.

(4) Silencing of NAMPT leads to up-regulation of insulin receptor substrate 1 gene expression in U87 glioma cellsEndocrine RegulationsJanuary 1, 2020Daria O. Tsymbal, Dmytro O. Minchenko, Olena Y. Luzina, Olena O. Riabovol, Serhiy V. Danilovskyi, Oleksandr H. Minchenkoincubator with 5% CO2. The silencing of NAMPT mRNA was introduced by NAMPT specific siRNA (PBEF siRNA (h), sc-45843, Santa Cruz Biotechnology, Inc., Dallas, TX, U.S.A.). Control siRNA-A (sc-37007, Santa Cruz Biotechnology, Inc

(5) Melatonin inhibits Sirt1-dependent NAMPT and NFAT5 signaling in chondrocytes to attenuate osteoarthritisOncotargetAugust 22, 2017Guo JY, Li F, Wen YB, Cui HX, Guo ML, Zhang L, Zhang YF, Guo YJ, Guo YX.

(6) Activation of farnesoid X receptor downregulates visfatin and attenuates diabetic nephropathyMolecular and cellular endocrinologyJanuary 5, 2016Zhou B, Feng B, Qin Z, Zhao Y, Chen Y, Shi Z, Gong Y, Zhang J, Yuan F, Mu J.

(7) Replicative Senescence in Human Fibroblasts Is Delayed by Hydrogen Sulfide in a NAMPT/SIRT1 Dependent MannerPloS oneJanuary 1, 2016Sanokawa-Akakura R, Akakura S, Tabibzadeh S.

(8) Dedifferentiation of cancer cells following recovery from a potentially lethal damage is mediated by H2S-NamptExperimental cell researchJanuary 1, 2015Ostrakhovitch EA, Akakura S, Sanokawa-Akakura R, Goodwin S, Tabibzadeh S.

(9) Nicotinamide adenine dinucleotide (NAD) may affect DNA methyltransferase 1 through regulation of BRCA1 in ovarian cancerAmerican journal of cancer researchJanuary 1, 2015Fang YY, Bi FF, Zhou YM, Sun WP, Li CY, Liu Q, Zhao Y, Li D.

(10) Regulative Effect of Nampt on Tumor Progression and Cell Viability in Human Colorectal CancerJournal of CancerJanuary 1, 2015Lv X, Zhang L, Zhu Y, Said HM, Shi J, Xu G.atmosphere. Human Nampt-siRNA was a pool of 3 target-specific siRNAs designed to knock down gene expression (sc-45843, Santa Cruz Biotechnology, Inc., Dallas, TX, USA). Non-targeting siRNA (sc-37007, Santa Cruz) was used

(11) A novel crosstalk between BRCA1 and sirtuin 1 in ovarian cancerScientific reportsOctober 17, 2014Li D, Bi FF, Chen NN, Cao JM, Sun WP, Zhou YM, Li CY, Yang Q.

(12) A novel crosstalk between BRCA1 and poly (ADP-ribose) polymerase 1 in breast cancerCell cycle (Georgetown, Tex.)January 1, 2014Li D, Bi FF, Chen NN, Cao JM, Sun WP, Zhou YM, Li CY, Yang Q.

(13) Targeting of NAD metabolism in pancreatic cancer cells: potential novel therapy for pancreatic tumorsClinical cancer research : an official journal of the American Association for Cancer ResearchJanuary 1, 2014Chini CC, Guerrico AM, Nin V, Camacho-Pereira J, Escande C, Barbosa MT, Chini EN.(HSC.RNAI.N001775.12.2) and Dharmacon (J-004581-06) were used. Nampt siRNAs were a pool of 3 target-specific siRNAs (sc-45843, Santa Cruz), and a human on-target plus probe (J-009222-05, Dharmacon). Transfections were performed

(14) BRCA1 as a nicotinamide adenine dinucleotide (NAD)-dependent metabolic switch in ovarian cancerCell cycle (Georgetown, Tex.)January 1, 2014Li D, Chen NN, Cao JM, Sun WP, Zhou YM, Li CY, Wang XX.

Be the First to Write a Review!

PBEF siRNA (h)

PBEF siRNA (h) from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (14)

Reviews

PBEF siRNA (h) from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map